Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001053310-08-000002
Filing Date
2008-08-14
Accepted
2008-08-14 20:28:53
Documents
1
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 inb5_geraldkayex.html 5  
1 inb5_geraldkayex.xml 5 23796
  Complete submission text file 0001053310-08-000002.txt   25713
Mailing Address 201 ROUTE 22 HILLSIDE NJ 07205
Business Address 201 ROUTE 22 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Issuer) CIK: 0001016504 (see all company filings)

EIN.: 133035216 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address C/O 201 ROUTE 22 HILLSIDE NJ 07205 9739260816
KAY E GERALD (Reporting) CIK: 0001053310 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-31668 | Film No.: 081021087